On Demand 2020 Sunday General Sessions

This collection covers general sessions from Sunday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:

  • How to Implement Updates from the Latest Clinical Guidelines Into Practice
  • SLIT vs SCIT - Let the Battle Begin
  • Coding and Government Relations 
  • Caring for Patients Across Multiple Populations
  • Masqueraders of Common Allergic Conditions
  • The AAAAI/ACAAI/CSACI North American Food Allergy Prevention Guidelines
  • GINA vs NHLBI Asthma Guidelines: How Do We Reconcile Differences?
  • The Challenges of Severe Conjunctival Inflammation

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 10.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Individualize asthma management with different approaches to medication, avoidance measures and use of biomarkers
  • Provide consistent messaging to patients with chronic rhinitis regarding a stepwise approach to medical management
  • Apply evidence surrounding risk for biphasic anaphylaxis towards clinical care. Recognize limitations in various diagnostic tests for peanut allergy
  • Review the evidence supporting benefit and cost-efficacy of SCIT, along with individual patient factors that may make SCIT the preferred choice
  • Review the evidence supporting benefit and cost-efficacy of SLIT, along with individual patient factors that may make SLIT the preferred choice
  • Discuss available options with patients and incorporate their preferences regarding risks, benefits and protocols into decision-making
  • Describe coding changes and updates relevant to allergy practice
  • Describe how allergists and organizations have been involved using past examples and calls to action for future work
  • Understand a governmental and legislative update for the allergist
  • Describe considerations for prognosis and treatment during pregnancy and as women age
  • Describe how diagnosis and management differs in the elderly
  • Describe the issues pertaining to the diagnosis and management of individuals from different ethnic and racial backgrounds
  • Utilize the clinical history and additional diagnostic testing to help evaluate patients with very elevated total IgE levels
  • Identify the appropriate differential diagnosis and evaluation for patients with peripheral eosinophilia
  • Identify autoimmune conditions with symptoms that overlap with allergic disorders
  • Describe the new prevention guidelines and highlight the changes relative to past/other society guidelines
  • Detail the potential policy implications from the new recommendations
  • Describe tips to optimize implementation and knowledge translation of new prevention recommendations to best support patients and medical professionals
  • Identify which themes from both guidelines can be applied to patient care
  • Identify which aspects are unique to GINA, and how can allergists implement these into patient care
  • Identify obstacles to adopting these changes in practice, as well as areas that remain unaddressed
  • Improve understanding of the pathophysiology of dry eye syndrome and allergic ocular conditions
  • Improve understanding of the diagnostic evaluation for dry eye syndrome and allergic ocular conditions
  • Utilize established and newer treatment outcomes in dry eye syndrome and allergic eye conditions.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2020 Annual Meeting is available online and via the meeting app.

Course summary
Available credit: 
  • 10.50 AMA PRA Category 1 Credit™
  • 10.50 Attendance
  • 10.50 CBRN
Course opens: 
11/17/2020
Course expires: 
11/29/2023
Rating: 
0

Todd A. Mahr, MD, FACAAI
Mark S. Dykewicz, MD, FACAAI
Marcus S. Shaker, MD, FACAAI
Matthew C. Greenhawt, MD, MBA, MSc, FACAAI
Myron J. Zitt, MD, FACAAI
Stanley M. Fineman, MD, MBA, FACAAI
David I. Bernstein, MD, FACAAI
Peter S. Creticos, MD
Desiree E. Larenas-Linnemann, FACAAI
James L. Sublett, MD, FACAAI
Warner W. Carr, MD, FACAAI
Gary N. Gross, MD, FACAAI
James M. Tracy, DO, FACAAI
Bill Finerfrock
Jeremy S. Katcher, MD, FACAAI
Jared Darveaux, MD
Jennifer Namazy, MD
Tolly E. Epstein, MD, MS, FACAAI
Andrea J. Apter, MD, FACAAI 
Eric Yen, MD
Melanie A. Ruffner, MD, PhD
Alexandra Freeman, MD
Princess Ogbogu, MD, FACAAI
Jennifer R. Heimall, MD
Susan Waserman, MD, FACAAI
Aikaterini Anagnostou, MD, PhD, FACAAI
Elissa M. Abrams, MD
Kirsten Perrett, MD
James M. Quinn, MD, FACAAI
Anthony J. Bonitatibus, MD
Jonathan A. Bernstein, MD, FACAAI
Angela D. Hogan, MD, FACAAI
Leonard B. Bacharier, MD, FACAAI
Jonathan M. Rodrigues, MD, FACAAI
Purvi S. Parikh, MD, FACAAI
Merin E. Kuruvilla, MD
Guillermo Amescua, MD
Leonard Bielory, MD, FACAAI

Available Credit

  • 10.50 AMA PRA Category 1 Credit™
  • 10.50 Attendance
  • 10.50 CBRN
Please login or create an account to take this course.